2- (4- methylphenoxy)- 7- (4- chlorophenyl)heptanoic acid

RN refers to (+)-isomer; an insulin-sensitizing agent; structure given in first source

Also Known As:

2-(4-methylphenoxy)-7-(4-chlorophenyl)heptanoic acid, (-)-isomer; BM 13.0913; BM 130913; BM-13.0913; BM-130913

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

1.	Insulin Resistance 05/01/1995 - "The new antidiabetic agent (-)-BM 13.0913.Na (BM) was administered to 12-week-old lean and obese Zucker rats, an animal model of insulin resistance, at a daily dose of 50 mg/kg for 14 days. " 05/01/1995 - "Effect of the new oral antidiabetic agent (-)-BM 13.0913.Na on insulin resistance in lean and obese Zucker rats." 05/01/1995 - "(-)-BM 13.0913, a member of this class, was effective in improving insulin resistance in hyperinsulinemic and hypoinsulinemic insulin-resistant animal models of NIDDM. " 05/01/1995 - "(-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus."
2.	Type 2 Diabetes Mellitus (MODY) 05/01/1995 - "(-)-BM 13.0913, a member of this class, was effective in improving insulin resistance in hyperinsulinemic and hypoinsulinemic insulin-resistant animal models of NIDDM. " 05/01/1995 - "(-)-BM 13.0913: a new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non-insulin-dependent) diabetes mellitus."

1.	Insulin (Novolin)
2.	Hypoglycemic Agents (Hypoglycemics)